Identification of human complement factor B as a novel biomarker candidate for pancreatic ductal adenocarcinoma

Journal of Proteome Research

Volumn 13, Issue 11, 2014, Pages 4878-4888

  Lee, Min Jung ^a,b   Na, Keun ^a   Jeong, Seul Ki ^a   Lim, Jong Sun ^a   Kim, Sun A ^c   Lee, Min Ji ^c   Song, Si Young ^c   Kim, Hoguen ^c   Hancock, William S ^d   Paik, Young Ki ^a,b  

^a Yonsei University   (South Korea)

^b Yonsei University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d NORTHEASTERN UNIVERSITY   (United States)

Author keywords

biomarker; carbohydrate antigen 19 9; complement factor b; pancreatic cancers

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; CA 19-9 ANTIGEN; PRIMER DNA; TRYPSIN; TUMOR MARKER;

ADULT; ARTICLE; BILE DUCT CARCINOMA; BLOOD SAMPLING; CHRONIC PANCREATITIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PANCREAS ADENOCARCINOMA; PANCREATIC CANCER CELL LINE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEROLOGY; STOMACH CANCER; AREA UNDER THE CURVE; BLOOD; CARCINOMA, PANCREATIC DUCTAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMAGE PROCESSING; METABOLISM; NONPARAMETRIC TEST; PANCREATIC NEOPLASMS; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; TUMOR CELL LINE; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

AREA UNDER CURVE; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; COMPLEMENT FACTOR B; DNA PRIMERS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOPRECIPITATION; PANCREATIC NEOPLASMS; PROTEOMICS; REAL-TIME POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; TANDEM MASS SPECTROMETRY; TRYPSIN;

EID: 84908890879     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr5002719     Document Type: Article

References (55)

1. World Health Organization. World Cancer Report 2014; International Agency for Research in Cancer: Lyon, France, 2014; Chapter 5.7.
2. Rahib, L.; Smith, B. D.; Aizenberg, R.; Rosenzweig, A. B.; Fleshman, J. M.; Matrisian, L. M. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States Cancer Res. 2014, 74 (11) 2913-2921
3. Siegel, R.; Naishadham, D.; Jemal, A. Cancer Statistics, 2013 Ca-Cancer J. Clin. 2013, 63 (1) 11-30
4. Guo, X.; Cui, Z. Current diagnosis and treatment of pancreatic cancer in China Pancreas 2005, 31 (1) 13-22
5. Gold, P.; Freedman, S. O. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques J. Exp. Med. 1965, 121, 439-462
6. Goonetilleke, K. S.; Siriwardena, A. K. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer Eur. J. Surg. Oncol. 2007, 33 (3) 266-270
7. Brody, J. R.; Witkiewicz, A. K.; Yeo, C. J. The past, present, and future of biomarkers: a need for molecular beacons for the clinical management of pancreatic cancer Adv. Surg. 2011, 45, 301-321
8. Lundin, J.; Roberts, P. J.; Kuusela, P.; Haglund, C. The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer Br. J. Cancer 1994, 69 (3) 515-519
9. Koprowski, H.; Herlyn, M.; Steplewski, Z.; Sears, H. F. Specific antigen in serum of patients with colon carcinoma Science 1981, 212 (4490) 53-55
10. Chan, A.; Diamandis, E. P.; Blasutig, I. M. Strategies for discovering novel pancreatic cancer biomarkers J. Proteomics 2013, 81, 126-134
11. Rosty, C.; Goggins, M. Early detection of pancreatic carcinoma Hematol./Oncol. Clin. North Am. 2002, 16 (1) 37-52
12. Engelen, M. J.; de Bruijn, H. W.; Hollema, H.; ten Hoor, K. A.; Willemse, P. H.; Aalders, J. G.; van der Zee, A. G. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors Gynecol. Oncol. 2000, 78 (1) 16-20
13. Wu, C. S.; Yen, C. J.; Chou, R. H.; Li, S. T.; Huang, W. C.; Ren, C. T.; Wu, C. Y.; Yu, Y. L. Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma PLoS One 2012, 7 (7) e39466
14. Shriver, Z.; Raguram, S.; Sasisekharan, R. Glycomics: a pathway to a class of new and improved therapeutics Nat. Rev. Drug Discovery 2004, 3 (10) 863-873
15. Tonack, S.; Aspinall-ODea, M.; Neoptolemos, J. P.; Costello, E. Pancreatic Cancer: Proteomic Approaches to a Challenging Disease Pancreatology 2009, 9 (5) 567-576
16. Paik, Y. K.; Kim, H.; Lee, E. Y.; Kwon, M. S.; Cho, S. Y. Overview and introduction to clinical proteomics Methods Mol. Biol. 2008, 428, 1-31
17. Kosanam, H.; Prassas, I.; Chrystoja, C. C.; Soleas, I.; Chan, A.; Dimitromanolakis, A.; Blasutig, I. M.; Rückert, F.; Gruetzmann, R.; Pilarsky, C.; Maekawa, M.; Brand, R.; Diamandis, E. P. Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues Mol. Cell. Proteomics 2013, 12 (10) 2820-2832
18. Cecconi, D.; Palmieri, M.; Donadelli, M. Proteomics in pancreatic cancer research Proteomics 2011, 11 (4) 816-828
19. He, X. Y.; Liu, B. Y.; Yao, W. Y.; Zhao, X. J.; Zheng, Z.; Li, J. F.; Yu, B. Q.; Yuan, Y. Z. Serum DJ-1 as a diagnostic marker and prognostic factor for pancreatic cancer J. Dig. Dis. 2011, 12 (2) 131-137
20. Bausch, D.; Thomas, S.; Mino-Kenudson, M.; Fernández-del, C. C.; Bauer, T. W.; Williams, M.; Warshaw, A. L.; Thayer, S. P.; Kelly, K. A. Plectin-1 as a novel biomarker for pancreatic cancer Clin. Cancer Res. 2011, 17 (2) 302-309
21. Chang, Y. T.; Wu, C. C.; Shyr, Y. M.; Chen, T. C.; Hwang, T. L.; Yeh, T. S.; Chang, K. P.; Liu, H. P.; Liu, Y. L.; Tsai, M. H.; Chang, Y. S.; Yu, J. S. Secretome-based identification of ULBP2 as a novel serum marker for pancreatic cancer detection PLoS One 2011, 6 (5) e20029
22. Chen, J.; Chen, L. J.; Xia, Y. L.; Zhou, H. C.; Yang, R. B.; Wu, W.; Lu, Y.; Hu, L. W.; Zhao, Y. Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma J. Cancer Res. Clin. Oncol. 2013, 139 (7) 1117-1127
23. Winter, J. M.; Yeo, C. J.; Brody, J. R. Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer J. Surg Oncol 2013, 107 (1) 15-22
24. Rutkowski, M. J.; Sughrue, M. E.; Kane, A. J.; Mills, S. A.; Parsa, A. T. Cancer and the complement cascade Mol. Cancer Res. 2010, 8 (11) 1453-1465
25. Rai, A. J.; Gelfand, C. A.; Haywood, B. C.; Warunek, D. J.; Yi, J.; Schuchard, M. D.; Mehigh, R. J.; Cockrill, S. L.; Scott, G. B.; Tammen, H.; Schulz-Knappe, P.; Speicher, D. W.; Vitzthum, F.; Haab, B. B.; Siest, G.; Chan, D. W. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples Proteomics 2005, 5 (13) 3262-3277
26. Cho, S. Y.; Lee, E. Y.; Lee, J. S.; Kim, H. Y.; Park, J. M.; Kwon, M. S.; Park, Y. K.; Lee, H. J.; Kang, M. J.; Kim, J. Y.; Yoo, J. S.; Park, S. J.; Cho, J. W.; Kim, H. S.; Paik, Y. K. Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map Proteomics 2005, 5 (13) 3386-3396
27. Na, K.; Lee, E. Y.; Lee, H. J.; Kim, K. Y.; Lee, H.; Jeong, S. K.; Jeong, A. S.; Cho, S. Y.; Kim, S. A.; Song, S. Y.; Kim, K. S.; Cho, S. W.; Kim, H.; Paik, Y. K. Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma Proteomics 2009, 9 (16) 3989-3999
28. Na, K.; Jeong, S. K.; Lee, M. J.; Cho, S. Y.; Kim, S. A.; Lee, M. J.; Song, S. Y.; Kim, H.; Kim, K. S.; Lee, H. W.; Paik, Y. K. Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients Int. J. Cancer 2013, 133 (2) 408-415
29. Choi, B. K.; Cho, Y. M.; Bae, S. H.; Zoubaulis, C. C.; Paik, Y. K. Single-step perfusion chromatography with a throughput potential for enhanced peptide detection by matrix-assisted laser desorption/ ionization-mass spectrometry Proteomics 2003, 3 (10) 1955-1961
30. Chung, H. W.; Wen, J.; Lim, J. B.; Bang, S.; Park, S. W.; Song, S. Y. Radiosensitization effect of STI-571 on pancreatic cancer cells in vitro Int. J. Radiat. Oncol., Biol., Phys. 2009, 75 (3) 862-869
31. Wang, J.; Ohno-Matsui, K.; Yoshida, T.; Kojima, A.; Shimada, N.; Nakahama, K.; Safranova, O.; Iwata, N.; Saido, T. C.; Mochizuki, M.; Morita, I. Altered Function of Factor I Caused by Amyloid β: Implication for Pathogenesis of Age-Related Macular Degeneration from Drusen J. Immunol. 2008, 181 (1) 712-720
32. Heider, U.; Zavrski, I.; Jakob, C.; Bängeroth, K.; Fleissner, C.; Langelotz, C.; Possinger, K.; Hofbauer, L. C.; Viereck, V.; Sezer, O. Expression of receptor activator of NF-kappaB ligand (RANKL) mRNA in human multiple myeloma cells J. Cancer Res. Clin. Oncol. 2004, 130 (8) 69-74
33. Zweig, M. H.; Campbell, G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine Clin. Chem. 1993, 39 (4) 561-577
34. Youden, W. J. Index for rating diagnostic tests Cancer 1950, 3 (1) 32-35
35. Jeong, S. K.; Na, K.; Kim, K. Y.; Kim, H.; Paik, Y. K. PanelComposer: a web-based panel construction tool for multivariate analysis of disease biomarker candidates J. Proteome Res. 2012, 11 (12) 6277-6281
36. Bloomston, M.; Zhou, J. X.; Rosemurgy, A. S.; Frankel, W.; Muro-Cacho, C. A.; Yeatman, T. J. Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples Cancer Res. 2006, 66 (5) 2592-2599
37. Chen, J.; Chen, L. J.; Yang, R. B.; Xia, Y. L.; Zhou, H. C.; Wu, W.; Lu, Y.; Hu, L. W.; Zhao, Y. Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma Med. Oncol. 2013, 30 (2) 583
38. Lochab, S.; Pal, P.; Kanaujiya, J. K.; Tripathi, S. B.; Kapoor, I.; Bhatt, M. L.; Sanyal, S.; Behre, G.; Trivedi, A. K. Proteomic identification of E6AP as a molecular target of tamoxifen in MCF7 cells Proteomics 2012, 12 (9) 1363-1377
39. Shu, H.; Kang, X.; Guo, K.; Li, S.; Li, M.; Sun, L.; Gan, L.; Liu, Y.; Qin, X. Diagnostic value of serum haptoglobin protein as hepatocellular carcinoma candidate marker complementary to α fetoprotein Oncol. Rep. 2010, 24 (5) 1271-1276
40. Chiellini, C.; Santini, F.; Marsili, A.; Berti, P.; Bertacca, A.; Pelosini, C.; Scartabelli, G.; Pardini, E.; López-Soriano, J.; Centoni, R.; Ciccarone, A. M.; Benzi, L.; Vitti, P.; Del Prato, S.; Pinchera, A.; Maffei, M. Serum haptoglobin: a novel marker of adiposity in humans J. Clin. Endocrinol. Metab. 2004, 89 (6) 2678-83
41. Chen, R.; Pan, S.; Brentnall, T. A.; Aebersold, R. Proteomic profiling of pancreatic cancer for biomarker discovery Mol. Cell. Proteomics 2005, 4 (4) 523-533
42. Wu, J.; Xie, X.; Liu, Y.; He, J.; Benitez, R.; Buckanovich, R. J.; Lubman, D. M. Identification and Confirmation of Differentially Expressed Fucosylated Glycoproteins in the Serum of Ovarian Cancer Patients Using a Lectin Array and LC-MS/MS J. Proteome Res. 2012, 11 (9) 4541-4552
43. Doustjalali, S. R.; Yusof, R.; Yip, C. H.; Looi, L. M.; Pillay, B.; Hashim, O. H. Aberrant expression of acute-phase reactant proteins in sera and breast lesions of patients with malignant and benign breast tumors Electrophoresis 2004, 25 (14) 2392-2401
44. Yu, K. H.; Rustgi, A. K.; Blair, I. A. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry J. Proteome Res. 2005, 4 (5) 1742-1751
45. Sakamoto, K.; Haga, Y.; Yoshimura, R.; Egami, H.; Yokoyama, Y.; Akagi, M. Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system Gut 1987, 28 (3) 323-329
46. Matalliotakis, I.; Panidis, D.; Vlassis, G.; Neonaki, M.; Goumenou, A.; Koumantakis, E. Unexpected increase of the CA 19-9 tumour marker in patients with endometriosis Eur. J. Gynaecol. Oncol. 1998, 19 (5) 498-500
47. Makawita, S.; Smith, C.; Batruch, I.; Zheng, Y.; Rückert, F.; Grützmann, R.; Pilarsky, C.; Gallinger, S.; Diamandis, E. P. Integrated Proteomic Profiling of Cell Line Conditioned Media and Pancreatic Juice for the Identification of Pancreatic Cancer Biomarkers Mol. Cell. Proteomics 2011, 10 (10) M111.008599
48. Wu, C. C.; Hsu, C. W.; Chen, C. D.; Yu, C. J.; Chang, K. P.; Tai, D. I.; Liu, H. P.; Su, W. H.; Chang, Y. S.; Yu, J. S. Candidate Serological Biomarkers for Cancer Identified from the Secretomes of 23 Cancer Cell Lines and the Human Protein Atlas Mol. Cell. Proteomics 2010, 9 (6) 1100-1117
49. Mastellos, D.; Lambris, J. D. Complement: more than a guard against invading pathogens? Trends Immunol. 2002, 23 (10) 485-491
50. Rutkowski, M. J.; Sughrue, M. E.; Kane, A. J.; Ahn, B. J.; Fang, S.; Parsa, A. T. The complement cascade as a mediator of tissue growth and regeneration Inflammation Res. 2010, 59 (11) 897-905
51. Zou, L.; Feng, Y.; Li, Y.; Zhang, M.; Chen, C.; Cai, J.; Gong, Y.; Wang, L.; Thurman, J. M.; Wu, X.; Atkinson, J. P.; Chao, W. Complement Factor B Is the Downstream Effector of TLRs and Plays an Important Role in a Mouse Model of Severe Sepsis J. Immunol 2013, 191 (11) 5625-5635
52. Tamburrino, A.; Piro, G.; Carbone, C.; Tortora, G.; Melisi, D. Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy Front. Pharmacol. 2013, 4, 56
53. Rutkowski, M. J.; Sughrue, M. E.; Kane, A. J.; Mills, S. A.; Fang, S.; Parsa, A. T. Complement and the central nervous system: emerging roles in development, protection and regeneration Immunol. Cell Biol. 2010, 88 (8) 781-786
54. Huang, Y.; Krein, P. M.; Winston, B. W. Characterization of IFN-gamma regulation of the complement factor B gene in macrophages Eur. J. Immunol. 2001, 31 (12) 3676-3686
55. Huang, Y.; Krein, P. M.; Muruve, D. A.; Winston, B. W. Complement Factor B Gene Regulation: Synergistic Effects of TNF-α and IFN-γ in Macrophages J. Immunol. 2002, 169 (5) 2627-2635